Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Ottawa

$15,000.00

Mediating role of corticotropin-releasing hormone (CRH) and opioid peptides in ischemia: behavioural and physiological correlates

FY 2006-07

Summary
Neuronal degeneration plays a major role in permanent psychological, cognitive and physical sequelae following cardiac arrest or stroke.  Therapeutic approaches mainly aimed at blocking calcium-mediated depolarization and glutamate excitotoxicity following ischemia have all been accompanied by unwanted side effects, which have prevented their use in clinical settings.  Thus, the search for the development of treatments able to safely and efficiently alter ischemia-induced neuronal degeneration continues.  Interestingly, evidence is beginning to accumulate suggesting that endogenous peptidergic signals may exert neuroprotective actions.  The principal objective of my research is to further characterize the involvement of opioid and CRH peptides in the physiological cascade mediating ischemia-induced neuronal damage.  The hippocampal damage associated with global ischemic insults provokes a number of behavioural and cognitive changes, mainly characterized by memory impairments in both animals and humans.  Thus, a critical component of the evaluation of putative neuroprotective compounds is their ability to reverse ischemia-induced functional impairments as well as neuronal damage.  In the characterization of the contribution of distinct peptide signals, my research also aims to determine the impact of treatments targeting these systems on ischemia-induced behavioural and memory impairments, using various tests.  It is hoped that behavioural assessments combined with cellular and molecular research findings can help broaden our understanding of the role of CRH and opioid peptides in ischemia, and evaluate their potential value in the development of new therapeutic strategies.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
217320-2006
Name nom
Plamondon, Hélène
Department département
Psychology, School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
15000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6300
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Psychology
Research subject fr
Psychologie
Partie
1
Nb partie
1
Application title
Mediating role of corticotropin-releasing hormone (CRH) and opioid peptides in ischemia: behavioural and physiological correlates
Keyword
NA
Application summary
Neuronal degeneration plays a major role in permanent psychological, cognitive and physical sequelae following cardiac arrest or stroke.  Therapeutic approaches mainly aimed at blocking calcium-mediated depolarization and glutamate excitotoxicity following ischemia have all been accompanied by unwanted side effects, which have prevented their use in clinical settings.  Thus, the search for the development of treatments able to safely and efficiently alter ischemia-induced neuronal degeneration continues.  Interestingly, evidence is beginning to accumulate suggesting that endogenous peptidergic signals may exert neuroprotective actions.  The principal objective of my research is to further characterize the involvement of opioid and CRH peptides in the physiological cascade mediating ischemia-induced neuronal damage.  The hippocampal damage associated with global ischemic insults provokes a number of behavioural and cognitive changes, mainly characterized by memory impairments in both animals and humans.  Thus, a critical component of the evaluation of putative neuroprotective compounds is their ability to reverse ischemia-induced functional impairments as well as neuronal damage.  In the characterization of the contribution of distinct peptide signals, my research also aims to determine the impact of treatments targeting these systems on ischemia-induced behavioural and memory impairments, using various tests.  It is hoped that behavioural assessments combined with cellular and molecular research findings can help broaden our understanding of the role of CRH and opioid peptides in ischemia, and evaluate their potential value in the development of new therapeutic strategies.